Adagio Medical Holdings (ADGM) Common Equity (2023 - 2026)

Adagio Medical Holdings (ADGM) has 4 years of Common Equity data on file, last reported at $5.7 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 53.83% year-over-year to $5.7 million; the trailing twelve-month figure through Mar 2026 stood at $5.7 million (down 53.83% YoY), and the FY2025 full-year result was $12.4 million, down 37.72% from the prior year.
• Common Equity retreated to $5.7 million in Q1 2026, from $12.4 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $76.6 million in Q3 2024 to a low of -$140.5 million in Q2 2024.
• A 4-year average of -$36.4 million and a median of $5.7 million in 2026 frame the typical range for Common Equity.
• Across the five-year window, Common Equity soared 161.99% in 2024 and plunged 101.71% in 2025, its largest moves.
• Tracing ADGM's Common Equity over 4 years: stood at -$132.0 million in 2023, then jumped by 115.08% to $19.9 million in 2024, then slumped by 37.72% to $12.4 million in 2025, then plunged by 53.84% to $5.7 million in 2026.
• Business Quant data shows ADGM's Common Equity at $5.7 million in Q1 2026, $12.4 million in Q4 2025, and -$1.3 million in Q3 2025.